Blanc M, Clanet M, Berr C, Dugoujon J M, Ruydavet B, Ducos S J, Rascol A, Alpérovitch A
J Neurol Sci. 1986 Aug;75(1):1-5. doi: 10.1016/0022-510x(86)90045-6.
Serum samples collected from 69 patients with multiple sclerosis (MS) living in the Hautes-Pyrénées county were tested for immunoglobulin Gm gamma 1, gamma 2, and gamma 3, heavy chain allotypes (Gm system), and immunoglobulin light chain Kappa (Km system). A control group was made up of normal individuals living in the same county. We found a significant excess of individuals with Gm3; +/- 23;5/Gm3; +/- 23;5 amongst the MS patients as compared with controls (relative risk = 2.4). A slight increase of the Km (1) frequency was found in MS patients compared with controls, 21.7% vs 11.8%, but this difference was not significant.
对居住在比利牛斯-大西洋省的69例多发性硬化症(MS)患者采集的血清样本进行免疫球蛋白Gmγ1、γ2和γ3重链同种异型(Gm系统)以及免疫球蛋白轻链κ(Km系统)检测。对照组由居住在同一省份的正常个体组成。我们发现,与对照组相比,MS患者中Gm3;+/- 23;5/Gm3;+/- 23;5个体显著过多(相对风险=2.4)。与对照组相比,MS患者中Km(1)频率略有增加,分别为21.7%和11.8%,但这种差异不显著。